TG Therapeutics Inc (NASDAQ:TGTX)

16.49
Delayed Data
As of Apr 17
 -0.68 / -3.96%
Today’s Change
4.42
Today|||52-Week Range
20.00
+4.10%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line-889.1K-26.2M-20.5M-55.8M
 
 
 
 
 
Depreciation--235.001.1K3.9K
 
 
 
 
Total Other Cash Flow390.6K20.4M5.5M26.8M
 
 
 
 
 
Funds From Operations-498.5K-5.8M-15.0M-29.0M
 
 
 
 
 
Funds From/For Other Operating Expenses-411.9K-644.0K-4.2M6.0M
 
 
 
 
 
Net Cash Flow - Operating Activities-86.6K-5.2M-10.8M-35.1M
 
 
 
 
 
 
InvestingIncrease In Investments0.000.00-4.9M-18.3M
 
 
 
Capital Expenditures0.00-1.4K-5.7K-18.6K
 
 
 
 
Fixed Asset Disposal10.4K0.00----
 
 
Net Cash Flow Investing10.4K-1.4K-4.9M-18.4M
 
 
 
 
 
 
FinancingShort Term Borrowings0.00-200.0K0.00-677.8K
 
 
 
Long Term Borrowings0.000.000.00-52.0K
 
 
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale9.8M12.2M39.9M69.4M
 
 
 
 
 
Common Preferred Redeemed0.00-84.5K-149.8K0.00
 
 
 
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing9.8M11.9M39.8M68.6M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----0.000.00--
 
Net Change In Cash9.7M6.7M24.0M15.2M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account